Holdings
Gilead Sciences, Inc.
As of Jun 30, 2026, Gilead Sciences, Inc. reported 4 positions worth US$1.64B. Largest: Arcus Biosciences, Inc., Lakefront Biotherapeutics and Assembly Biosciences, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Arcus Biosciences, Inc. | 31.4M | US$969M | no change | Jun 30, 2026 |
| Lakefront Biotherapeutics | 16.7M | US$500M | no change | Jun 30, 2026 |
| Assembly Biosciences, Inc. | 4.98M | US$137M | +472K | Jun 30, 2026 |
| Kyverna Therapeutics, Inc. | 4.13M | US$36.8M | no change | Jun 30, 2026 |